These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17889852)

  • 61. Variability of Botulinum Toxins: Challenges and Opportunities for the Future.
    Rasetti-Escargueil C; Lemichez E; Popoff MR
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30217070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.
    Pier CL; Chen C; Tepp WH; Lin G; Janda KD; Barbieri JT; Pellett S; Johnson EA
    FEBS Lett; 2011 Jan; 585(1):199-206. PubMed ID: 21126520
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.
    Whitemarsh RC; Tepp WH; Bradshaw M; Lin G; Pier CL; Scherf JM; Johnson EA; Pellett S
    Infect Immun; 2013 Oct; 81(10):3894-902. PubMed ID: 23918782
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells.
    Whitemarsh RC; Tepp WH; Johnson EA; Pellett S
    PLoS One; 2014; 9(2):e90252. PubMed ID: 24587301
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin.
    Ayyar BV; Tajhya RB; Beeton C; Atassi MZ
    Sci Rep; 2015 Oct; 5():15776. PubMed ID: 26508475
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes.
    Doellgast GJ; Triscott MX; Beard GA; Bottoms JD
    J Clin Microbiol; 1994 Mar; 32(3):851-3. PubMed ID: 8195408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Egg yolk antibodies for detection and neutralization of Clostridium botulinum type A neurotoxin.
    Trott DL; Yang M; Gonzalez J; Larson AE; Tepp WH; Johnson EA; Cook ME
    J Food Prot; 2009 May; 72(5):1005-11. PubMed ID: 19517727
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.
    Siegel LS
    J Clin Microbiol; 1989 Aug; 27(8):1906-8. PubMed ID: 2768475
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test.
    Worbs S; Fiebig U; Zeleny R; Schimmel H; Rummel A; Luginbühl W; Dorner BG
    Toxins (Basel); 2015 Nov; 7(12):4935-66. PubMed ID: 26703724
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of specific immune responses to BoNT/A and tetanus toxoid in patients undergoing treatment for neurologic disorders.
    Vlata Z; Tsatsakis A; Tzagournissakis M; Krambovitis E
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):268-73. PubMed ID: 22385115
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An optical biosensor assay for rapid dual detection of Botulinum neurotoxins A and E.
    Lévêque C; Ferracci G; Maulet Y; Mazuet C; Popoff MR; Blanchard MP; Seagar M; El Far O
    Sci Rep; 2015 Dec; 5():17953. PubMed ID: 26648139
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Zebrafish Sensitivity to Botulinum Neurotoxins.
    Chatla K; Gaunt PS; Petrie-Hanson L; Ford L; Hanson LA
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27153088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Substrate-based inhibitors exhibiting excellent protective and therapeutic effects against Botulinum Neurotoxin A intoxication.
    Guo J; Wang J; Gao S; Ji B; Waichi Chan E; Chen S
    Sci Rep; 2015 Nov; 5():16981. PubMed ID: 26584873
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics.
    Duchesne de Lamotte J; Perrier A; Martinat C; Nicoleau C
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299143
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sensitive assay for measurement of antibodies to Clostridium botulinum neurotoxins A, B, and E: use of hapten-labeled-antibody elution to isolate specific complexes.
    Doellgast GJ; Brown JE; Koufman JA; Hatheway CL
    J Clin Microbiol; 1997 Mar; 35(3):578-83. PubMed ID: 9041392
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays.
    Schenke M; Schjeide BM; Püschel GP; Seeger B
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.
    Welch MJ; Purkiss JR; Foster KA
    Toxicon; 2000 Feb; 38(2):245-58. PubMed ID: 10665805
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection.
    Whitemarsh RC; Strathman MJ; Chase LG; Stankewicz C; Tepp WH; Johnson EA; Pellett S
    Toxicol Sci; 2012 Apr; 126(2):426-35. PubMed ID: 22223483
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
    Poulain B; Popoff MR
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30641949
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunogenicity Associated with Botulinum Toxin Treatment.
    Bellows S; Jankovic J
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.